Novavax, Inc. (NVAX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous close | 16.85 |
| Open | 16.50 |
| Bid | 16.33 x 800 |
| Ask | 16.45 x 1200 |
| Day's range | 15.53 - 16.55 |
| 52-week range | 15.53 - 236.50 |
| Volume | |
| Avg. volume | 5,044,230 |
| Market cap | 1.297B |
| Beta (5Y monthly) | 1.89 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Novavax (NVAX) COVID Jab Gets Expanded Label in WHO's EUL
The WHO updates Emergency Use Listing (EUL) for Novavax's (NVAX) COVID-19 vaccine to include its use as a primary series in adolescents and for use as a booster dose in adults.
- Zacks
Do Options Traders Know Something About Novavax (NVAX) Stock We Don't?
Investors need to pay close attention to Novavax (NVAX) stock based on the movements in the options market lately.
- Zacks
Novavax (NVAX) Stock Nosedives 88% This Year: Here's Why
Novavax (NVAX) drops to record lows as the delayed product launch of its COVID-19 vaccine made it lose market share. Management slashes revenue guidance by more than half.
© 2022 Yahoo. All rights reserved.
